Effects of Gabexate Mesylate on the Gut Microbiota and Metabolomics in Rats with Sepsis

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Sun J, Ding X, Sun T. Mesenchymal stem cells in sepsis: from basic research to clinical application. Intensive Care Res. 2021;1(1–2):2–10. doi:10.2991/icres.k.210622.001
   Google Scholar
• Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–1562. doi:10.1007/s00134-020-06151-x
   PubMed Web of Science ®Google Scholar
• Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181–1247. doi:10.1007/s00134-021-06506-y
   PubMed Web of Science ®Google Scholar
• Zheng MH, Bai JL, Meng MB, et al. Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis update. Curr Ther Res Clin Exp. 2008;69(4):288–304. doi:10.1016/j.curtheres.2008.08.001
   PubMed Web of Science ®Google Scholar
• Yoo YW, Cha SW, Kim A, et al. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Gut Liver. 2012;6(2):256–261. doi:10.5009/gnl.2012.6.2.256
   PubMed Web of Science ®Google Scholar
• Akahoshi T, Sugimori H, Kaku N, et al. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study. Eur J Trauma Emerg Surg. 2015;41(5):531–538. doi:10.1007/s00068-014-0478-4
   PubMed Web of Science ®Google Scholar
• Urano T, Ihara H, Suzuki Y, et al. Coagulation-associated enhancement of fibrinolytic activity via a neutralization of PAI-1 activity. Semin Thromb Hemost. 2000;26(1):39–42. doi:10.1055/s-2000-9801
   PubMed Web of Science ®Google Scholar
• Xiang M, Wu X, Jing H, et al. The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors. Front Immunol. 2022;13:955654. doi:10.3389/fimmu.2022.955654
   PubMed Web of Science ®Google Scholar
• Oh SH, Lee HY, Ki YJ, et al. Gabexate mesilate ameliorates the neuropathic pain in a rat model by inhibition of proinflammatory cytokines and nitric oxide pathway via suppression of nuclear factor-κB. Korean J Pain. 2020;33(1):30–39. doi:10.3344/kjp.2020.33.1.30
   PubMed Web of Science ®Google Scholar
• Hidaka S, Iwasaka H, Hagiwara S, et al. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury. J Surg Res. 2011;165(1):142–150. doi:10.1016/j.jss.2009.05.039
   PubMed Web of Science ®Google Scholar
• Murakami K, Okajima K, Uchiba M, et al. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes. Crit Care Med. 1996;24(6):1047–1053. doi:10.1097/00003246-199606000-00027
   PubMed Web of Science ®Google Scholar
• Xie LB, Zeng DY, Wang XD, et al. Preconditioning with gabexate is superior to inosine for ameliorating acute renal ischemia-reperfusion injury in rats. Transplant Proc. 2014;46(1):40–45. doi:10.1016/j.transproceed.2013.10.037
   PubMed Web of Science ®Google Scholar
• Niehaus GD, Kimura R, Traber LD, et al. Administration of a synthetic antiprotease reduces smoke-induced lung injury. J Appl Physiol. 1990;69(2):694–699. doi:10.1152/jappl.1990.69.2.694
   PubMed Web of Science ®Google Scholar
• Park I, Kim M, Choe K, et al. Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury. Eur Respir J. 2019;53(3):1800786. doi:10.1183/13993003.00786-2018
   PubMed Web of Science ®Google Scholar
• Uchiba M, Okajima K, Kaun C, et al. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro. Crit Care Med. 2003;31(4):1147–1153. doi:10.1097/01.CCM.0000060005.48885.2B
   PubMed Web of Science ®Google Scholar
• Levi M, Van Der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38–44. doi:10.1016/j.thromres.2016.11.007
   PubMed Web of Science ®Google Scholar
• Tsai HJ, Ding C, Tsao CM, et al. Effects of gabexate mesilate on coagulopathy and organ dysfunction in rats with endotoxemia: a potential use of thrombelastography in endotoxin-induced sepsis. Blood Coagul Fibrinolysis. 2015;26(2):175–184. doi:10.1097/MBC.0000000000000214
   PubMed Web of Science ®Google Scholar
• Lee YT, Wei J, Chuang YC, et al. Successful treatment with continuous enteral protease inhibitor in a patient with severe septic shock. Transplant Proc. 2012;44(3):817–819. doi:10.1016/j.transproceed.2012.03.032
   PubMed Web of Science ®Google Scholar
• Imhann F, Vich Vila A, Bonder MJ, et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut. 2018;67(1):108–119. doi:10.1136/gutjnl-2016-312135
   PubMed Web of Science ®Google Scholar
• Li H, Zhai R, Liang H, et al. [Analysis of the changes in intestinal microecology in the early stage of sepsis rat based on 16S rDNA sequencing]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34(1):28–34. Chinese. doi:10.3760/cma.j.cn121430-20201215-00754
   PubMedGoogle Scholar
• Dickson RP. The microbiome and critical illness. Lancet Respir Med. 2016;4(1):59–72. doi:10.1016/S2213-2600(15)00427-0
   PubMed Web of Science ®Google Scholar
• Liu W, Cheng M, Li J, et al. Classification of the gut microbiota of patients in intensive care units during development of sepsis and septic shock. Genomics Proteomics Bioinformatics. 2020;18(6):696–707. doi:10.1016/j.gpb.2020.06.011
   PubMed Web of Science ®Google Scholar
• Wang C, Li Q, Tang C, et al. Characterization of the blood and neutrophil-specific microbiomes and exploration of potential bacterial biomarkers for sepsis in surgical patients. Immun Inflamm Dis. 2021;9(4):1343–1357. doi:10.1002/iid3.483
   PubMed Web of Science ®Google Scholar
• Du B, Shen N, Tao Y, et al. Analysis of gut microbiota alteration and application as an auxiliary prognostic marker for sepsis in children: a pilot study. Transl Pediatr. 2021;10(6):1647–1657. doi:10.21037/tp-21-51
   PubMed Web of Science ®Google Scholar
• Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 2019;12(4):843–850. doi:10.1038/s41385-019-0160-6
   PubMed Web of Science ®Google Scholar
• Brown RL, Sequeira RP, Clarke TB. The microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun. 2017;8(1):1512. doi:10.1038/s41467-017-01803-x
   PubMed Web of Science ®Google Scholar
• Chunxi L, Haiyue L, Yanxia L, et al. The gut microbiota and respiratory diseases: new evidence. J Immunol Res. 2020;2020:2340670. doi:10.1155/2020/2340670
   PubMed Web of Science ®Google Scholar
• Roduit C, Frei R, Ferstl R, et al. High levels of butyrate and propionate in early life are associated with protection against atopy. Allergy. 2019;74(4):799–809. doi:10.1111/all.13660
   PubMed Web of Science ®Google Scholar
• Cait A, Hughes MR, Antignano F, et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal Immunol. 2018;11(3):785–795. doi:10.1038/mi.2017.75
   PubMed Web of Science ®Google Scholar
• Antunes KH, Fachi JL, De Paula R, et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun. 2019;10(1):3273. doi:10.1038/s41467-019-11152-6
   PubMed Web of Science ®Google Scholar
• Sencio V, Barthelemy A, Tavares LP, et al. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep. 2020;30(9):2934–2947.e6. doi:10.1016/j.celrep.2020.02.013
   PubMed Web of Science ®Google Scholar
• Wu T, Li H, Su C, et al. Microbiota-derived short-chain fatty acids promote LAMTOR2-mediated immune responses in macrophages. mSystems. 2020;5:6. doi:10.1128/mSystems.00587-20
   Web of Science ®Google Scholar
• Wu T, Xu F, Su C, et al. Alterations in the gut microbiome and cecal metabolome during Klebsiella pneumoniae-induced pneumosepsis. Front Immunol. 2020;11:1331. doi:10.3389/fimmu.2020.01331
   PubMed Web of Science ®Google Scholar
• Ebrahimi-Mameghani M, Sanaie S, Mahmoodpoor A, et al. Effect of a probiotic preparation (VSL#3) in critically ill patients: a randomized, double-blind, placebo-controlled trial (pilot study). Pak J Med Sci. 2013;29(2):490–494. doi:10.12669/pjms.292.3370
   PubMed Web of Science ®Google Scholar
• Gai X, Wang H, Li Y, et al. Fecal microbiota transplantation protects the intestinal mucosal barrier by reconstructing the gut microbiota in a murine model of sepsis. Front Cell Infect Microbiol. 2021;11:736204. doi:10.3389/fcimb.2021.736204
   PubMed Web of Science ®Google Scholar
• Cui Y, Liu S, Zhang X, et al. Metabolomic analysis of the effects of adipose-derived mesenchymal stem cell treatment on rats with sepsis-induced acute lung injury. Front Pharmacol. 2020;11:902. doi:10.3389/fphar.2020.00902
   PubMed Web of Science ®Google Scholar
• Liang H, Ding X, Yu Y, et al. Adipose-derived mesenchymal stem cells ameliorate acute liver injury in rat model of CLP induced-sepsis via sTNFR1. Exp Cell Res. 2019;383(1):111465. doi:10.1016/j.yexcr.2019.06.010
   PubMed Web of Science ®Google Scholar
• Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60. doi:10.1186/gb-2011-12-6-r60
   PubMed Web of Science ®Google Scholar
• Osman MO, Kristensen JU, Jacobsen NO, et al. A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut. 1998;43(2):232–239. doi:10.1136/gut.43.2.232
   PubMed Web of Science ®Google Scholar
• Haak BW, Levi M, Wiersinga WJ. Microbiota-targeted therapies on the intensive care unit. Curr Opin Crit Care. 2017;23(2):167–174. doi:10.1097/MCC.0000000000000389
   PubMed Web of Science ®Google Scholar
• Sun T, Wang L, Zhang H. Intestinal microbiota in sepsis. Intensive Care Res. 2022;2(1–2):1–7. doi:10.1007/s44231-022-00001-8
   Google Scholar
• Mariaule V, Kriaa A, Soussou S, et al. Digestive inflammation: role of proteolytic dysregulation. Int J Mol Sci. 2021;22:6. doi:10.3390/ijms22062817
   Web of Science ®Google Scholar
• Dabek M, Ferrier L, Annahazi A, et al. Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease-activated receptor-4. Inflamm Bowel Dis. 2011;17(6):1409–1414. doi:10.1002/ibd.21454
   PubMed Web of Science ®Google Scholar
• Allam-Ndoul B, Castonguay-Paradis S, Veilleux A. Gut microbiota and intestinal trans-epithelial permeability. Int J Mol Sci. 2020;21(17):6402. doi:10.3390/ijms21176402
   PubMed Web of Science ®Google Scholar
• Jiang L, Yang L, Zhang M, et al. Beneficial effects of ulinastatin on gut barrier function in sepsis. Indian J Med Res. 2013;138(6):904–911.
   PubMedGoogle Scholar
• Madsen K. Probiotics in critically ill patients. J Clin Gastroenterol. 2008;42:S116–8. doi:10.1097/MCG.0b013e31817283cb
   PubMed Web of Science ®Google Scholar
• Goldstein EJ, Tyrrell KL, Citron DM. Lactobacillus species: taxonomic complexity and controversial susceptibilities. Clin Infect Dis. 2015;60(Suppl 2):S98–107. doi:10.1093/cid/civ072
   PubMed Web of Science ®Google Scholar
• Shimizu K, Yamada T, Ogura H, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Crit Care. 2018;22(1):239. doi:10.1186/s13054-018-2167-x
   PubMed Web of Science ®Google Scholar
• Robertson C, Savva GM, Clapuci R, et al. Incidence of necrotising enterocolitis before and after introducing routine prophylactic Lactobacillus and Bifidobacterium probiotics. Arch Dis Child Fetal Neonatal Ed. 2020;105(4):380–386. doi:10.1136/archdischild-2019-317346
   PubMed Web of Science ®Google Scholar
• Yang G, Xu C, Varjani S, et al. Metagenomic insights into improving mechanisms of Fe(0) nanoparticles on volatile fatty acids production from potato peel waste anaerobic fermentation. Bioresour Technol. 2022;361:127703. doi:10.1016/j.biortech.2022.127703
   PubMed Web of Science ®Google Scholar
• Liu S, Li E, Sun Z, et al. Altered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder. Sci Rep. 2019;9(1):287. doi:10.1038/s41598-018-36430-z
   PubMed Web of Science ®Google Scholar
• Sivaprakasam S, Gurav A, Paschall AV, et al. An essential role of Ffar2 (Gpr43) in dietary fibre-mediated promotion of healthy composition of gut microbiota and suppression of intestinal carcinogenesis. Oncogenesis. 2016;5(6):e238. doi:10.1038/oncsis.2016.38
   PubMed Web of Science ®Google Scholar
• Liu H, Wang J, He T, et al. Butyrate: a double-edged sword for health?. Adv Nutr. 2018;9(1):21–29. doi:10.1093/advances/nmx009
   PubMed Web of Science ®Google Scholar
• Sun J, Ding X, Liu S, et al. Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats. Stem Cell Res Ther. 2020;11(1):384. doi:10.1186/s13287-020-01902-5
   PubMed Web of Science ®Google Scholar
• Wang W, Chen Q, Yang X, et al. Sini decoction ameliorates interrelated lung injury in septic mice by modulating the composition of gut microbiota. Microb Pathog. 2020;140:103956. doi:10.1016/j.micpath.2019.103956
   PubMed Web of Science ®Google Scholar
• Nishiwaki H, Hamaguchi T, Ito M, et al. Short-chain fatty acid-producing gut microbiota is decreased in Parkinson’s disease but not in rapid-eye-movement sleep behavior disorder. mSystems. 2020;5:6. doi:10.1128/mSystems.00797-20
   Web of Science ®Google Scholar
• Baxter NT, Zackular JP, Chen GY, et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome. 2014;2:20. doi:10.1186/2049-2618-2-20
   PubMed Web of Science ®Google Scholar
• Ganesh BP, Klopfleisch R, Loh G, et al. Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS One. 2013;8(9):e74963. doi:10.1371/journal.pone.0074963
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cao H, Song N, et al. Long-term hexavalent chromium exposure facilitates colorectal cancer in mice associated with changes in gut microbiota composition. Food Chem Toxicol. 2020;138:111237. doi:10.1016/j.fct.2020.111237
   PubMed Web of Science ®Google Scholar
• Seibert B, Cáceres CJ, Cardenas-Garcia S, et al. Mild and severe SARS-CoV-2 infection induces respiratory and intestinal microbiome changes in the K18-hACE2 transgenic mouse model. Microbiol Spectr. 2021;9(1):e0053621. doi:10.1128/Spectrum.00536-21
   PubMed Web of Science ®Google Scholar
• Yan X, Yan J, Xiang Q, et al. Fructooligosaccharides protect against OVA-induced food allergy in mice by regulating the Th17/Treg cell balance using tryptophan metabolites. Food Funct. 2021;12(7):3191–3205. doi:10.1039/D0FO03371E
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262–1267. doi:10.1126/science.1223813
   PubMed Web of Science ®Google Scholar
• Zheng X, Xie G, Zhao A, et al. The footprints of gut microbial-mammalian co-metabolism. J Proteome Res. 2011;10(12):5512–5522. doi:10.1021/pr2007945
   PubMed Web of Science ®Google Scholar
• Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA. 2009;106(10):3698–3703. doi:10.1073/pnas.0812874106
   PubMed Web of Science ®Google Scholar
• Cuevas-Sierra A, Ramos-Lopez O, Riezu-Boj JI, et al. Diet, gut microbiota, and obesity: links with host genetics and epigenetics and potential applications. Adv Nutr. 2019;10(suppl_1):S17–s30. doi:10.1093/advances/nmy078
   PubMed Web of Science ®Google Scholar
• Hylemon PB, Zhou H, Pandak WM, et al. Bile acids as regulatory molecules. J Lipid Res. 2009;50(8):1509–1520. doi:10.1194/jlr.R900007-JLR200
   PubMed Web of Science ®Google Scholar
• Strnad P, Tacke F, Koch A, et al. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14(1):55–66. doi:10.1038/nrgastro.2016.168
   PubMed Web of Science ®Google Scholar
• Jin P, Deng S, Tian M, et al. INT-777 prevents cognitive impairment by activating Takeda G protein-coupled receptor 5 (TGR5) and attenuating neuroinflammation via cAMP/ PKA/ CREB signaling axis in a rat model of sepsis. Exp Neurol. 2021;335:113504. doi:10.1016/j.expneurol.2020.113504
   PubMed Web of Science ®Google Scholar
• Hao H, Cao L, Jiang C, et al. Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis. Cell Metab. 2017;25(4):856–867.e5. doi:10.1016/j.cmet.2017.03.007
   PubMed Web of Science ®Google Scholar
• Xiong X, Ren Y, Cui Y, et al. Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation. Biomed Pharmacother. 2017;96:1292–1298. doi:10.1016/j.biopha.2017.11.083
   PubMed Web of Science ®Google Scholar
• Rao MS, Papreddy K, Musunuri S, et al. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats. In Vivo. 2002;16(2):145–152.
   PubMed Web of Science ®Google Scholar
• Medina-Gomez G, Gray SL, Yetukuri L, et al. PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 2007;3(4):e64. doi:10.1371/journal.pgen.0030064
   PubMed Web of Science ®Google Scholar